Continued medical education credit hours: Are they being awarded too liberally?
- 1*
- 1Department of Pharmacology, M. P. Shah Medical College, Jamnagar, Gujarat, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Anupama Sukhlecha
Department of Pharmacology, M. P. Shah Medical College, Jamnagar, Gujarat, India.
Email: anupama_acad@yahoo.co.in
Copyright: © 2013 The Author(s). This is an open access article.
Published: Jan 1, 2013
- DOI
- Not available yet
Abstract
Credit points are being distributed like prasad (temple offerings). Just to gain credit hours, doctors are attending different specialty CME meets.[5] Our body cannot be compartmentalized to subjects, so, any doctor can attend CME on any specialty and get credit hours. However, weightage should be given to credit points awarded in his/her specialty. Similarly, credit points should preferably be given to those who subscribe to journals and are members of associations of their specialty.
Keywords
Subject
Recommended articles
- Abuse of topical corticosteroids in India: Concerns and the way forward
Subodh Kumar, Aman Goyal, Yogendra Kumar Gupta · Journal of Pharmacology and Pharmacotherapeutics
- What failed BIA 10–2474 Phase I clinical trial? Global speculations and recommendations for future Phase I trials
Rimplejeet Kaur, Preeti Sidhu, Surjit Singh · Journal of Pharmacology and Pharmacotherapeutics
- The metabolic syndrome and schizophrenia: A comorbidity or an association?
· Journal of Pharmacology and Pharmacotherapeutics
- How full is our antihypertensives pipeline?
Dilip Gude · Journal of Pharmacology and Pharmacotherapeutics
- Phenylpropanolamine and the hemorrhagic stroke: A new search for the culprit
Mostafa Yakoot · Journal of Pharmacology and Pharmacotherapeutics
- Research publications: Should they be mandatory for promotions of medical teachers?
Anupama Sukhlecha · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions
Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei
Jan 1, 2025
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026